{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:57:03Z","timestamp":1785419823480,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008678","name":"Universit\u00e4t Leipzig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms that impair quality of life. Inpatient Parkinson\u2019s disease Multimodal Complex Treatment (PD-MCT) integrates individualized medication adjustments with intensive multiprofessional therapies and improves symptoms and functional abilities. However, evidence remains limited regarding which symptom domains benefit most and which patient characteristics predict treatment response, particularly in advanced PD and with respect to cognitive status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This two-center, prospective cohort study included 53 adults with advanced idiopathic PD who underwent 14\u201321\u00a0days of inpatient PD-MCT at two centers. Inclusion criteria comprised a diagnosis of PD according to German and International Parkinson and Movement Disorder Society guidelines and the ability to walk at least 50\u00a0m with assistive devices. Patients with atypical parkinsonian syndromes or comorbidities severely affecting gait were excluded. Motor function, non-motor symptoms, cognition, and quality of life were assessed at baseline and before discharge. A 3-month follow-up evaluated symptom burden and continuation of supportive therapies. Primary outcomes were changes in motor symptom severity (\u0394MDS-UPDRS-III), overall motor function (\u0394MDS-UPDRS-II\u2009+\u2009III\u2009+\u2009IV), and quality of life (\u0394PDQ-39).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PD-MCT significantly improved motor symptom severity (\u22125.2\u2009\u00b1\u200910.6), overall motor function (\u221210.6\u2009\u00b1\u200910.7), and quality of life (\u22129.3\u2009\u00b1\u200916.2). Additional benefits were observed in non-motor symptoms, cognition, mood, and functional measures. Greater baseline motor impairment and poorer quality of life predicted larger short-term improvements, while baseline cognition did not influence treatment effectiveness. Predictive modelling showed modest predictive value of baseline motor scores for changes in MDS-UPDRS-III.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings confirm that PD-MCT provides clinically meaningful motor, non-motor, cognitive, and quality-of-life benefits in advanced PD, with strongest effects in patients with high baseline symptom burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-13697-1","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:12:45Z","timestamp":1771431165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive effects of Parkinson\u2019s disease multimodal complex treatment (PD-MCT): a two-center prospective trial"],"prefix":"10.1007","volume":"273","author":[{"given":"Isabel","family":"Friedrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gutschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Weise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost-Julian","family":"Rumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Classen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"13697_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS et al (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"key":"13697_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03739-4","volume":"24","author":"C Wattenbach","year":"2024","unstructured":"Wattenbach C, Ellrichmann G, Feinkohl I et al (2024) Incidence of Parkinson\u2019s disease in Germany based on prevalence data from 70 million patients of the statutory health insurance. BMC Neurol 24:221. https:\/\/doi.org\/10.1186\/s12883-024-03739-4","journal-title":"BMC Neurol"},{"key":"13697_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"13697_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14737167.2024.2390042","volume":"25","author":"F van der Meer","year":"2025","unstructured":"van der Meer F, Jorgensen J, Hiligsmann M (2025) Burden of non-motor symptoms of Parkinson\u2019s disease: cost-of-illness and quality-of-life estimates through a scoping review. Expert Rev Pharmacoecon Outcomes Res 25:17\u201327. https:\/\/doi.org\/10.1080\/14737167.2024.2390042","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"13697_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ncl.2024.12.008","volume":"43","author":"JG Goldman","year":"2025","unstructured":"Goldman JG (2025) Non-motor symptoms and treatments in Parkinson\u2019s disease. Neurol Clin 43:291\u2013317. https:\/\/doi.org\/10.1016\/j.ncl.2024.12.008","journal-title":"Neurol Clin"},{"key":"13697_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ncl.2024.12.009","volume":"43","author":"M Fabbri","year":"2025","unstructured":"Fabbri M, Corvol JC, Rascol O (2025) Disease-modifying therapies in Parkinson\u2019s disease. Neurol Clin 43:319\u2013340. https:\/\/doi.org\/10.1016\/j.ncl.2024.12.009","journal-title":"Neurol Clin"},{"key":"13697_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293826","volume":"18","author":"C Padilha","year":"2023","unstructured":"Padilha C, Souza R, Grossl FS et al (2023) Physical exercise and its effects on people with Parkinson\u2019s disease: umbrella review. PLoS ONE 18:e0293826. https:\/\/doi.org\/10.1371\/journal.pone.0293826","journal-title":"PLoS ONE"},{"key":"13697_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0041-1725133","volume":"41","author":"TD Ellis","year":"2021","unstructured":"Ellis TD, Col\u00f3n-Semenza C, DeAngelis TR et al (2021) Evidence for early and regular physical therapy and exercise in Parkinson\u2019s disease. Semin Neurol 41:189\u2013205. https:\/\/doi.org\/10.1055\/s-0041-1725133","journal-title":"Semin Neurol"},{"key":"13697_CR9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00415-019-09657-7","volume":"267","author":"R Scherbaum","year":"2020","unstructured":"Scherbaum R, Hartelt E, Kinkel M et al (2020) Parkinson\u2019s disease multimodal complex treatment improves motor symptoms, depression and quality of life. J Neurol 267:954\u2013965. https:\/\/doi.org\/10.1007\/s00415-019-09657-7","journal-title":"J Neurol"},{"key":"13697_CR10","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1007\/s00415-022-11257-x","volume":"269","author":"R Scherbaum","year":"2022","unstructured":"Scherbaum R, Moewius A, Oppermann J et al (2022) Parkinson\u2019s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study. J Neurol 269:6067\u20136085. https:\/\/doi.org\/10.1007\/s00415-022-11257-x","journal-title":"J Neurol"},{"key":"13697_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mdc3.13578","volume":"10","author":"K Ziegler","year":"2023","unstructured":"Ziegler K, Messner M, Paulig M et al (2023) Activities of daily living are improved by inpatient multimodal complex treatment for PD-a real-world cohort study. Mov Disord Clin Pract 10:42\u201354. https:\/\/doi.org\/10.1002\/mdc3.13578","journal-title":"Mov Disord Clin Pract"},{"key":"13697_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/bs.irn.2017.02.001","volume":"132","author":"MA Qamar","year":"2017","unstructured":"Qamar MA, Harington G, Trump S et al (2017) Multidisciplinary care in Parkinson\u2019s disease. Int Rev Neurobiol 132:511\u2013523. https:\/\/doi.org\/10.1016\/bs.irn.2017.02.001","journal-title":"Int Rev Neurobiol"},{"key":"13697_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-024-02807-w","volume":"131","author":"D Weise","year":"2024","unstructured":"Weise D, Claus I, Dresel C et al (2024) Multidisciplinary care in Parkinson\u2019s disease. J Neural Transm (Vienna) 131:1217\u20131227. https:\/\/doi.org\/10.1007\/s00702-024-02807-w","journal-title":"J Neural Transm (Vienna)"},{"key":"13697_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-02963-7","author":"R Scherbaum","year":"2025","unstructured":"Scherbaum R, H\u00f6llerhage M, Klebe S et al (2025) Parkinson\u2019s disease multidisciplinary complex therapy (PD-MCT): appreciation of its current function for the treatment of people with Parkinson\u2019s disease in Germany and the needs of future development. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-025-02963-7","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"13697_CR15","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1016\/S1353-8020(09)70819-3","volume":"15","author":"MA van der Marck","year":"2009","unstructured":"van der Marck MA, Kalf JG, Sturkenboom IHWM et al (2009) Multidisciplinary care for patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 15(3):S219\u2013S223. https:\/\/doi.org\/10.1016\/S1353-8020(09)70819-3","journal-title":"Parkinsonism Relat Disord"},{"key":"13697_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11111460","author":"KG Heimrich","year":"2021","unstructured":"Heimrich KG, Prell T (2021) Short- and long-term effect of Parkinson\u2019s disease multimodal complex treatment. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11111460","journal-title":"Brain Sci"},{"key":"13697_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061874","author":"E Hartelt","year":"2020","unstructured":"Hartelt E, Scherbaum R, Kinkel M et al (2020) Parkinson\u2019s disease multimodal complex treatment (PD-MCT): analysis of therapeutic effects and predictors for improvement. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9061874","journal-title":"J Clin Med"},{"key":"13697_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00702-017-1701-3","volume":"124","author":"T M\u00fcller","year":"2017","unstructured":"M\u00fcller T, \u00d6hm G, Eilert K et al (2017) Benefit on motor and non-motor behavior in a specialized unit for Parkinson\u2019s disease. J Neural Transm (Vienna) 124:715\u2013720. https:\/\/doi.org\/10.1007\/s00702-017-1701-3","journal-title":"J Neural Transm (Vienna)"},{"key":"13697_CR19","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/mds.26256","volume":"30","author":"M Monticone","year":"2015","unstructured":"Monticone M, Ambrosini E, Laurini A et al (2015) In-patient multidisciplinary rehabilitation for Parkinson\u2019s disease: a randomized controlled trial. Mov Disord 30:1050\u20131058. https:\/\/doi.org\/10.1002\/mds.26256","journal-title":"Mov Disord"},{"key":"13697_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0891988719841721","volume":"32","author":"K Marumoto","year":"2019","unstructured":"Marumoto K, Yokoyama K, Inoue T et al (2019) Inpatient enhanced multidisciplinary care effects on the quality of life for Parkinson disease: a quasi-randomized controlled trial. J Geriatr Psychiatry Neurol 32:186\u2013194. https:\/\/doi.org\/10.1177\/0891988719841721","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"13697_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/1545968311416990","volume":"26","author":"G Frazzitta","year":"2012","unstructured":"Frazzitta G, Bertotti G, Riboldazzi G et al (2012) Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up. Neurorehabil Neural Repair 26:144\u2013150. https:\/\/doi.org\/10.1177\/1545968311416990","journal-title":"Neurorehabil Neural Repair"},{"key":"13697_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02647-9","volume":"22","author":"L Wagner","year":"2022","unstructured":"Wagner L, Hauptmann B, Hoffmann A-K et al (2022) Evaluation of an individualized, tablet-based physiotherapy training programme for patients with Parkinson\u2019s disease: the ParkProTrain study, a quasi-randomised controlled trial. BMC Neurol 22:176. https:\/\/doi.org\/10.1186\/s12883-022-02647-9","journal-title":"BMC Neurol"},{"key":"13697_CR23","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.parkreldis.2015.10.006","volume":"21","author":"K Horv\u00e1th","year":"2015","unstructured":"Horv\u00e1th K, Aschermann Z, \u00c1cs P et al (2015) Minimal clinically important difference on the motor examination part of MDS-UPDRS. Parkinsonism Relat Disord 21:1421\u20131426. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.10.006","journal-title":"Parkinsonism Relat Disord"},{"key":"13697_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000455863","volume":"48","author":"K Horv\u00e1th","year":"2017","unstructured":"Horv\u00e1th K, Aschermann Z, Kov\u00e1cs M et al (2017) Changes in quality of life in Parkinson\u2019s disease: how large must they be to be relevant? Neuroepidemiology 48:1\u20138. https:\/\/doi.org\/10.1159\/000455863","journal-title":"Neuroepidemiology"},{"key":"13697_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.gaitpost.2023.11.016","volume":"108","author":"ST Baudendistel","year":"2023","unstructured":"Baudendistel ST, Haussler AM, Rawson KS et al (2023) Minimal clinically important differences of spatiotemporal gait variables in Parkinson disease. Gait Posture 108:257\u2013263. https:\/\/doi.org\/10.1016\/j.gaitpost.2023.11.016","journal-title":"Gait Posture"},{"key":"13697_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2018.08.018","volume":"58","author":"A Makkos","year":"2019","unstructured":"Makkos A, Kov\u00e1cs M, Pint\u00e9r D et al (2019) Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale. Parkinsonism Relat Disord 58:79\u201382. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.08.018","journal-title":"Parkinsonism Relat Disord"},{"key":"13697_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ageing\/30.4.299","volume":"30","author":"V Peto","year":"2001","unstructured":"Peto V, Jenkinson C, Fitzpatrick R (2001) Determining minimally important differences for the PDQ-39 Parkinson\u2019s disease questionnaire. Age Ageing 30:299\u2013302. https:\/\/doi.org\/10.1093\/ageing\/30.4.299","journal-title":"Age Ageing"},{"key":"13697_CR28","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/jnnp-2017-316437","volume":"89","author":"D Ferrazzoli","year":"2018","unstructured":"Ferrazzoli D, Ortelli P, Zivi I et al (2018) Efficacy of intensive multidisciplinary rehabilitation in Parkinson\u2019s disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 89:828\u2013835. https:\/\/doi.org\/10.1136\/jnnp-2017-316437","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13697_CR29","unstructured":"H\u00f6glinger G., Trenkwalder C et al (2023) Parkinson-Krankheit: S2k-Leitlinie. Accessed 14 Aug 2025"},{"key":"13697_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020151","author":"D Richter","year":"2019","unstructured":"Richter D, Bartig D, Muhlack S et al (2019) Dynamics of Parkinson\u2019s disease multimodal complex treatment in Germany from 2010\u20132016: patient characteristics, access to treatment, and formation of regional centers. Cells. https:\/\/doi.org\/10.3390\/cells8020151","journal-title":"Cells"},{"key":"13697_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/906274","volume":"2013","author":"NE Allen","year":"2013","unstructured":"Allen NE, Schwarzel AK, Canning CG (2013) Recurrent falls in Parkinson\u2019s disease: a systematic review. Parkinsons Dis 2013:906274. https:\/\/doi.org\/10.1155\/2013\/906274","journal-title":"Parkinsons Dis"},{"key":"13697_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/mds.26960","volume":"32","author":"K Horv\u00e1th","year":"2017","unstructured":"Horv\u00e1th K, Aschermann Z, Kov\u00e1cs M et al (2017) Minimal clinically important differences for the experiences of daily living parts of movement disorder society-sponsored unified Parkinson\u2019s disease rating scale. Mov Disord 32:789\u2013793. https:\/\/doi.org\/10.1002\/mds.26960","journal-title":"Mov Disord"},{"key":"13697_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00007256-200434050-00005","volume":"34","author":"GR Hunter","year":"2004","unstructured":"Hunter GR, McCarthy JP, Bamman MM (2004) Effects of resistance training on older adults. Sports Med 34:329\u2013348. https:\/\/doi.org\/10.2165\/00007256-200434050-00005","journal-title":"Sports Med"},{"key":"13697_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/CIA.S231359","volume":"15","author":"A de Vieira Moraes Filho","year":"2020","unstructured":"de Vieira Moraes Filho A, Chaves SN, Martins WR et al (2020) Progressive resistance training improves bradykinesia, motor symptoms and functional performance in patients with Parkinson\u2019s disease. Clin Interv Aging 15:87\u201395. https:\/\/doi.org\/10.2147\/CIA.S231359","journal-title":"Clin Interv Aging"},{"key":"13697_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2019.06.001","volume":"147","author":"MKY Mak","year":"2019","unstructured":"Mak MKY, Wong-Yu ISK (2019) Exercise for Parkinson\u2019s disease. Int Rev Neurobiol 147:1\u201344. https:\/\/doi.org\/10.1016\/bs.irn.2019.06.001","journal-title":"Int Rev Neurobiol"},{"key":"13697_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60050711","author":"D-H Lee","year":"2024","unstructured":"Lee D-H, Woo B-S, Park Y-H et al (2024) General treatments promoting independent living in Parkinson\u2019s patients and physical therapy approaches for improving gait-A comprehensive review. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina60050711","journal-title":"Medicina (Kaunas)"},{"key":"13697_CR37","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","volume":"12","author":"GM Petzinger","year":"2013","unstructured":"Petzinger GM, Fisher BE, McEwen S et al (2013) Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson\u2019s disease. Lancet Neurol 12:716\u2013726. https:\/\/doi.org\/10.1016\/S1474-4422(13)70123-6","journal-title":"Lancet Neurol"},{"key":"13697_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12984-024-01430-w","volume":"21","author":"A Skrzatek","year":"2024","unstructured":"Skrzatek A, Nuic D, Cherif S et al (2024) Brain modulation after exergaming training in advanced forms of Parkinson\u2019s disease: a randomized controlled study. J Neuroeng Rehabil 21:133. https:\/\/doi.org\/10.1186\/s12984-024-01430-w","journal-title":"J Neuroeng Rehabil"},{"key":"13697_CR39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1212\/WNL.0000000000001282","volume":"84","author":"AJ Espay","year":"2015","unstructured":"Espay AJ, Norris MM, Eliassen JC et al (2015) Placebo effect of medication cost in Parkinson disease: a randomized double-blind study. Neurology 84:794\u2013802. https:\/\/doi.org\/10.1212\/WNL.0000000000001282","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13697-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13697-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13697-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:04:23Z","timestamp":1773785063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13697-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13697"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13697-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was conducted in accordance with the ethical standards of the responsible ethics committees and with applicable national and institutional guidelines. Ethical approval was obtained from the Ethics Committee of the Faculty of Medicine, University of Leipzig (approval number: 215\/22-ek; primary approval), and from the State Medical Association of Thuringia (registration number: 79148\/2023\/67).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"150"}}